K-PAX Pharmaceuticals, Inc. (The Nations 1st Integrative Medicine Pharmaceutical Company) Email Format

PharmaceuticalsCalifornia, United States11-50 Employees

K-PAX Pharmaceuticals, Inc. is a privately held biotech company focused on developing proprietary compounds to alleviate fatigue, decreased alertness, and impaired cognition in patients with Parkinson’s disease, Alzheimer’s disease, and cancer-related fatigue. Its lead compound, KPAX002, is a modified version of methylphenidate designed to provide a safer central nervous system stimulant effect, supported by proprietary mitochondrial technology. The company emphasizes addressing a significant unmet medical need by improving fatigue and alertness in chronically ill populations, with regulatory pathways being pursued for multiple indications including Parkinson’s non-motor symptoms, Alzheimer’s decreased alertness, cancer-related fatigue, and myalgic encephalomyelitis. Based in Mill Valley, California, K-PAX operates in the pharmaceutical manufacturing sector and has a work force that reflects a small to mid-sized biotech operation. The organization has conducted several clinical trials indicating safety and efficacy in reducing severe fatigue and fatigue-related symptoms in its target patient groups. Recent activity includes ongoing development across its indicated disease areas, aligned with a broader interest in fatigue treatment across multiple disease states. } }{

Get verified K-PAX Pharmaceuticals, Inc. (The Nations 1st Integrative Medicine Pharmaceutical Company) emails free

Company overview Employee directory